Try our beta test site

Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
VentiRx Pharmaceuticals Inc. Identifier:
First received: April 12, 2013
Last updated: January 5, 2016
Last verified: January 2016